市场调查报告书
商品编码
1534364
眼科器材市场:全球规模、份额、趋势分析、机会、预测,2019-2030Ophthalmological Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast, 2019-2030, Segmented By Devices; By End User; By Region |
2030年全球眼科器材市场规模将成长至570亿美元
由于眼科疾病盛行率不断上升、人口迅速老化、眼睛健康意识不断增强以及对微创手术的需求不断增长,全球眼科器械市场正在蓬勃发展。
领先的策略咨询和市场研究公司 BlueWeave Consulting 在最近的一项研究中估计,2023 年全球眼科器材市场规模将以金额为准412 亿美元。 BlueWeave 预测,在 2024 年至 2030 年的预测期内,全球眼科器材市场规模将以 4.80% 的复合年增长率成长,并于 2030 年达到 570 亿美元。技术进步、新兴国家对设备的需求不断增加以及人们对眼睛健康意识的提高是全球眼科设备市场的主要成长要素。新兴国家可支配收入的增加和医疗基础设施的改善为市场公司提供了成长机会。主要策略包括新产品发布、业务扩张、收购、合作伙伴关係和细胞疗法。眼科手术(例如超音波和雷射辅助手术)的进步提高了治疗效果和视力预防。
机会-更多采用创新技术
由于神经移植治疗、生物工程角膜、人造角膜、视网膜移植、干眼症检测、人工水晶体、隐形眼镜、雷射等方面的进步,全球眼科器械市场预计将成长。穿戴式 AR/VR 护目镜、基于人工智慧的治疗方法和生物感测器也有潜力增强眼科检查和监测。因此,先进技术的快速采用可能会在未来几年推动全球眼科器械市场的成长。
北美主导全球市场
按地区划分,北美在全球眼科器械市场中占据主导地位。北美市场的主导地位主要是由先进的医疗基础设施、眼科疾病的高盛行率、先进眼科技术的大量采用以及不断上涨的医疗成本所推动的。大型市场参与者和完善的医疗保健系统的存在也是北美在全球市场中保持主导地位的因素。
地缘政治紧张局势加剧对全球眼科器材市场的影响
地缘政治紧张局势的加剧对全球眼科器械市场产生重大影响。贸易限制和关税扰乱了供应链,增加了生产成本并延迟了重要零件的交付。製造商和医疗保健提供者在维持库存和满足需求方面面临挑战。此外,受影响地区的外汇波动和经济不稳定可能导致眼科设备价格上涨,并降低患者的可及性。经济不确定性可能会减少研发投资,进而可能减缓该领域的创新。此外,医疗保健预算可能会被重新调整以解决眼前的地缘政治危机,从而影响眼保健的资金。总的来说,这些因素可能是一个可变因素,阻碍全球眼科器械市场的成长。
竞争格局
全球眼科器械市场竞争激烈,众多公司争夺更大的市场占有率。市场主要企业包括爱尔康公司、博士健康公司、卡尔蔡司医疗公司、EssilorLuxottica SA、HAAG-Streit Group、霍亚公司、强生公司、尼德克有限公司、拓普康公司、齐默眼科系统公司、 Volk Optical, Inc. 和徕卡显微系统公司。这些公司正在采用各种策略来在全球眼科器械市场中定位自己,包括增加对研发活动的投资、併购、合资企业、联盟、许可协议以及新产品和服务 它的发布,并进一步加强。
该报告的详细分析提供了有关全球眼科器械市场的成长潜力、未来趋势和统计数据的资讯。它还涵盖了推动市场规模预测的因素。该报告致力于提供全球眼科器材市场的最新技术趋势以及产业见解,以帮助决策者做出适当的策略决策。此外,我们也分析了市场的成长动力、挑战和竞争力。
Global Ophthalmological Devices Market Size Expanding to Reach Value of USD 57 Billion by 2030
Global Ophthalmological Devices Market is flourishing due to the growing prevalence of eye diseases, the rapidly aging population, rising awareness about eye health, and an increasing demand for minimally invasive surgical procedures.
BlueWeave Consulting, a leading strategic consulting and Market research firm, in its recent study, estimated Global Ophthalmological Devices Market size by value at USD 41.2 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Ophthalmological Devices Market size to expand at a CAGR of 4.80% reaching a value of USD 57 billion in 2030. Technological advancements, rising demand for the devices from emerging economies, and increasing awareness about eye health are major growth factors for Global Ophthalmological Devices Market. Rising disposable income and improved healthcare infrastructure in developing countries create growth opportunities for the market players. Key strategies include new product launches, expansion, acquisitions, partnerships, and cell-based treatments. Advancements in eye surgery, such as phacoemulsification and laser-assisted procedures, have improved treatment efficacy and vision prevention.
Opportunity - Growing adoption of innovative technologies
The Ophthalmological Devices Market across the globe is expected to grow due to advancements in nerve transplant treatments, bioengineered Corneas, artificial corneas, retinal implants, dry eye syndrome detection, intraocular lenses, contact lenses, and lasers. Wearable AR and VR goggles, AI-based therapies, and biosensors could also enhance eye tests and monitoring. Hence, rapid adoption of advanced technologies could boost the growth of Global Ophthalmological Devices Market in the coming years.
North America Region Dominates the Global Market
North America dominates Global Ophthalmological Devices Market by region. The market dominance of North America is primarly driven by advanced healthcare infrastructure, a high prevalence of eye disorders, significant adoption of advanced ophthalmological technologies, and increasing healthcare expenditure. The presence of major market players and a well-established healthcare system also contribute to North America's leadership position in the global market.
Impact of Escalating Geopolitical Tensions on Global Ophthalmological Devices Market
Escalating geopolitical tensions significantly impact Global Ophthalmological Devices Market. Trade restrictions and tariffs disrupt the supply chain, leading to increased production costs and delayed delivery of essential components. It creates challenges for manufacturers and healthcare providers in maintaining inventory and meeting demand. Additionally, fluctuating exchange rates and economic instability in affected regions can result in higher prices for ophthalmological devices, reducing accessibility for patients. Investment in research and development may decline due to economic uncertainties, stalling innovations in the field. Furthermore, healthcare budgets might be redirected to address immediate geopolitical crises, impacting funding for ophthalmological care. These factors collectively contribute to volatility and may hinder the growth of Global Ophthalmological Devices Market.
Competitive Landscape
Global Ophthalmological Devices Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, EssilorLuxottica SA, HAAG-Streit Group, Hoya Corporation, Johnson and Johnson, Nidek Co. Ltd, Topcon Corporation, Ziemer Ophthalmological Systems AG, Volk Optical, Inc., and Leica Microsystems. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Global Ophthalmological Devices Market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Ophthalmological Devices Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Global Ophthalmological Devices Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the Market.
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable